Ransomware victim disclosure
← All victimsBristol Myers Squibb
listed as bms.com · Claimed by apt73 · listed 23 days ago
Status timeline
- Listed
Apr 27, 2026
- Data leaked
At a glance
- Group
- apt73
- Status
- Data leaked
- Country
- US
- Sector
- Healthcare
- Listed on leak site
- Apr 27, 2026
About the victim
AI dossier — public-source company profileBristol Myers Squibb (BMS) is a global biopharmaceutical company headquartered in the United States that discovers, develops, and delivers innovative medicines for serious diseases including cancer, cardiovascular conditions, and immunological disorders. The company operates across the Americas, Asia Pacific, Europe, and the Middle East, with manufacturing, research, and commercial operations worldwide. BMS is one of the largest pharmaceutical companies globally, with tens of thousands of employees and multi-billion dollar annual revenues.
- Industry
- Biopharmaceutical & Drug Development
- Employees
- 10000+
- Founded
- 1887
Attack summary
Severity: high — Confirmed exfiltration and publication of personal data from a major global biopharmaceutical company operating in the healthcare sector; PII exposure from a company of this scale and sensitivity warrants high severity, though the stated volume (302 lines) is relatively limited, preventing a critical rating.The group apt73 claims to have exfiltrated personal data from Bristol Myers Squibb, specifically advertising 302 lines of personal data as proof of the breach, with the disclosure status marked as data_published.
Data the group says was taken
AI dossier — extracted from the leak post- Personal data (302 records)
The group's post references roughly 1 proof file.
What the group claims
Pharmaceutical company. personal data - 302 lines
Sources
Source
Indexed 23 days agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
